Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank75
3Y CAGR+121.3%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+121.3%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
10.8x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$8.25M-7.4%
2024$8.90M+93.3%
2023$4.61M+505.3%
2022$761000.00+888.3%
2021$77000.00-